Following the correct sequence prevents common mixing errors that compromise research quality
The evidence supports its use for improving glycaemic control in type 2 diabetes, with weight loss being a beneficial secondary effect
This signaling represents one of the most sophisticated channels in this networka direct line from your gut to multiple organs orchestrating coordinated metabolic responses
A meta-regression study suggested a linear relationship between HbA1c reduction and MACE risk in patient with arGLP-1.89 Publication on mediation analyses also suggest that cardiovascular benefit could be mediated in part by effects on HbA1c, on blood pressure or reduction in urine albumin-creatinine ratio90,91 (see below), as well as by their effect on lipid profile.81 However, in subgroup analyses of cardiovascular safety studies, baseline HbA1c, weight, previous cardiovascular disease, or renal function did not predict the beneficial effects of these drugs on MACE,87 so other mechanisms, such as the previously mentioned anti-inflammatory, antifibrotic, antiatherogenic, vasodilator, or endothelial function-enhancing effects, have been suggested to influence the cardiovascular benefit of these drugs29,78 (Fig

But dont fret: Just because somethings new doesnt make it the best, and a range of weight loss medications and treatment plans are already on hand today, such as: semaglutide (Wegovy, Ozempic) tirzepatide (Zepbound, Mounjaro) liraglutide (Sazenda) orforglipron, a form of oral semaglutide (Foundayo) naltrexone and bupropion (Contrave) A clinician can help match you with the right treatment based on a range of factors, such as your goals, risks to your health, and side-effect history